Gauhati High Court Issues Notice To Union, Nagaland Govts On PIL Seeking Implementation Of National Blood Policy
The Gauhati High Court on Wednesday issued notice to the Union Government and the Nagaland Government on a Public Interest Litigation (PIL) petition filed praying for implementation of the National Blood Policy and the guidelines issued by the Ministry of Health & Family Welfare in the certain districts of Nagaland.The Bench of Justice Songkhupchung Serto and Justice S. Hukato Swu issued...
The Gauhati High Court on Wednesday issued notice to the Union Government and the Nagaland Government on a Public Interest Litigation (PIL) petition filed praying for implementation of the National Blood Policy and the guidelines issued by the Ministry of Health & Family Welfare in the certain districts of Nagaland.
The Bench of Justice Songkhupchung Serto and Justice S. Hukato Swu issued the notices and posted the matter for further hearing after 4 weeks.
As per the National Blood Policy, published by the Ministry of Health and Family Welfare Government of India in the year 2017, the policy aims to ensure an easily accessible and adequate supply of safe and quality blood and blood components collected/procured from a voluntary non-remunerated regular blood donor in well-equipped premises, which is free from transfusion-transmitted infections, and is stored and transported under optimum conditions.
The objectives of the Policy are as follows:
- To reiterate firmly the Govt. commitment to provide a safe and adequate quantity of blood, blood components, and blood products.
- To make available adequate resources to develop and reorganize the blood transfusion services in the entire country.
- To make the latest technology available for operating the blood transfusion services and ensure its functioning in an updated manner.
- To launch extensive awareness programmes for donor information, education, motivation, recruitment, and retention in order to ensure adequate availability of safe blood.
- To encourage appropriate clinical use of blood and blood products.
- To strengthen the manpower through human resource development.
- To encourage Research & Development in the field of Transfusion Medicine and related technology.
- To take adequate regulatory and legislative steps for monitoring and evaluation of blood transfusion services and to take steps to eliminate profiteering in blood banks.
Read Order